Search History
Clear
Trending Searches
Refresh
avatar
Sign Out
Home > Information > Quick News
Is the U.S. Planning a "Biological War"? Congress Sounds the Alarm
2025-04-10 11:00:47

Recently, the Emerging Biotechnology National Security Commission submitted an important report and action plan to the U.S. Congress, stating that urgent action is needed to address the biological technology challenges posed by China. The commission said: For decades, the United States has been the global leader in the field of biotechnology innovation, and now, the United States is dangerously lagging behind China. This 215-page report states that China is rapidly rising to become the dominant force in the field of biotechnology. If the United States does not take action within the next three years, it will face the risk of being permanently behind. To ensure that the United States leads the future of biotechnology, the commission believes that the U.S. government should invest at least $15 billion over the next five years, and provides related suggestions from six aspects.

Related Breaking News
  • 2025-04-28 13:54:57
    South Korea Continues to Impose Anti-Dumping Duties of Up to 25.04% for Five Years on Oriented Polypropylene Film from China

    Recently, South KoreaThe Ministry of Economy and Finance issued Decree No. 1125,Decide to continue imposing measures on oriented polyesters originating from China, Indonesia, and Thailand with a thickness exceeding 10 microns. A five-year anti-dumping duty is imposed on the film.(See attached table), including,The tax rate in China is 2.50% to 25.04%.The tariff numbers of the**** products in Korea are 3920.20.0000 and 3921.90.2000. The measures shall enter into force on the date of publication of the notice.

    Expand
  • 2025-04-25 09:55:43
    Roche Announces $360 Billion Investment in the U.S.

    Roche recently announced that it will invest $50 billion in the United States over the next five years. These investments further strengthen Roche's already significant footprint in the U.S., where it has 13 manufacturing and 15 research and development sites in the pharmaceutical and diagnostics sectors. It is expected to create over 12,000 new jobs, including nearly 6,500 construction jobs and 1,000 positions for the building and expansion of facilities.

    Expand
  • 2025-04-23 09:24:41
    Trump: Tariffs on Imports from China Are Too High, Expected to Significantly Reduce Them

    U.S. President Trump delivered a speech in a public venue on Tuesday (April 22) local time,He acknowledged that the current tariffs on imports from China are too high and predicted a significant reduction in tariff rates.This marks a shift in Trump's attitude towards his signature tariff policy. On Tuesday, U.S. Treasury Secretary Becerra also stated at a JPMorgan event that the trade war between China and the U.S. will soon cool down.

    Expand
  • 2025-04-23 08:06:37
    IMF Downgrades Global Growth Forecast Amid U.S. Tariff Measures Impact

    On April 22, local time, the International Monetary Fund released the latest World Economic Outlook report, lowering its global economic growth forecast for 2025 from 3.3% at the beginning of the year to 2.8%. The projection for 2026 is expected to be 3%. The impact of U.S. tariff measures and policy uncertainties will lead to a significant slowdown in the global economy in the short term.

    Expand
  • 2025-04-22 13:47:25
    $8.7 Billion M&A Finalized: Global Orthopedics Giant Doubles Down on High-Growth Sector

    On April 21, Zimmer Biomet, a global leader in orthopedics (NYSE: ZBH), announced the completion of its acquisition of Paragon 28. The deal is valued at $1.2 billion (approximately 8.7 billion RMB). Paragon 28 offers a wide range of surgical products and systems covering all major areas of the foot and ankle, including fractures and trauma, deformity correction, as well as joint replacement.

    Expand
Most Popular